Pimobendan Chewable Tablets

ACTIVE INGREDIENTS

Pimobendan

INDICATIONS FOR USE

Used for the treatment of canine congestive heart failure caused by insufficiency of heart valves (mitral and/or tricuspid regurgitation) or dilated cardiomyopathy. It is used for the treatment of preclinical dilated cardiomyopathy in large dogs (asymptomatic, diagnosed by echocardiography with enlarged left ventricular end-systolic and end-diastolic diameters). It is used for the treatment of preclinical myxomatous mitral valve disease in dogs (asymptomatic systolic mitral valve murmur and cardiac enlargement), and to delay the occurrence of clinical symptoms of congestive heart failure

DOSAGE AND ADMINISTRATION

Measured in pimobenzene. Oral administration: 0.25mg per 1kg of body weight for dogs, twice a day. For dogs weighing approximately 10 kilograms, give half a 5mg chewable tablet in the morning and half in the evening respectively. For dogs weighing approximately 20 kilograms, a 5mg chewable tablet was given in the morning and evening respectively.
Food can be consumed one hour after administration. Diuretics (such as furosemide) can be used in combination. Long-term continuous administration can be given to dogs with congestive heart failure

PACK SIZE